The DNA nanotechnology market is booming, driven by precision medicine and AI integration. Over 1,500 research projects and 300 clinical trials highl ...
The "POC (Point-of-care) Biosensors Market"is anticipated to ... focus on personalized medicine have propelled demand for these devices. According to recent estimates, the global POC biosensors market ...
A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency virus (HIV) detection that combines paper-based sample preparation with real ...
Mike is a Chartered Scientist and Fellow of the Institute of Biomedical Sciences with 36 years experience specialising in Haematology, Blood Transfusion and Point of Care devices for all disciplines.
VitalConnect announced today that it closed a $100 million financing through a combination of equity and debt capital.
The development of a highly sensitive electrochemical aptasensor is reported that combines the unique properties of graphene, metallic oxides, and conducting polymers to overcome the limitations of ...
Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer at the point of care. The eponymous ...
The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.
Home testing firm LetsGetChecked announced on Tuesday that its ImPress lancing device has received 510(k) clearance from the US Food and Drug Administration for professional use. The single-use blood ...
Centre for Integrative Semiconductor Materials (CISM), Faculty of Science and Engineering, Swansea University─Bay Campus, Fabian Way, Swansea SA1 8EN, U.K. Centre for Integrative Semiconductor ...
Feb. 14, 2025 — The Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and NTT Research, Inc., a division of NTT, announced the publication of research showing an ...